These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33581594)

  • 1. A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India.
    Gupta Y; Goyal A; Kubihal S; Golla KK; Tandon N
    Diabetes Metab Syndr; 2021; 15(1):407-413. PubMed ID: 33581594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed guidelines for screening of hyperglycemia in patients hospitalized with COVID-19 in low resource settings.
    Goyal A; Gupta S; Gupta Y; Tandon N
    Diabetes Metab Syndr; 2020; 14(5):753-756. PubMed ID: 32502958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of diabetes and hyperglycaemia in the hospital.
    Pasquel FJ; Lansang MC; Dhatariya K; Umpierrez GE
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):174-188. PubMed ID: 33515493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia: an independent risk factor for poor outcome in children with traumatic brain injury*.
    Elkon B; Cambrin JR; Hirshberg E; Bratton SL
    Pediatr Crit Care Med; 2014 Sep; 15(7):623-31. PubMed ID: 24849146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
    Sardu C; D'Onofrio N; Balestrieri ML; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Paolisso G; Marfella R
    Diabetes Care; 2020 Jul; 43(7):1408-1415. PubMed ID: 32430456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy.
    Mirzaei F; Khodadadi I; Vafaei SA; Abbasi-Oshaghi E; Tayebinia H; Farahani F
    Prim Care Diabetes; 2021 Jun; 15(3):409-416. PubMed ID: 33436320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19.
    Calvisi SL; Ramirez GA; Scavini M; Da Prat V; Di Lucca G; Laurenzi A; Gallina G; Cavallo L; Borio G; Farolfi F; Pascali M; Castellani J; Lampasona V; D'Angelo A; Landoni G; Ciceri F; Querini PR; Tresoldi M; Piemonti L
    Metabolism; 2021 Oct; 123():154845. PubMed ID: 34364927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU.
    Chow KW; Kelly DJ; Rieff MC; Skala PA; Kravets I; Charitou MM; Morley EJ; Gupta R; Miller JD
    J Diabetes Sci Technol; 2021 May; 15(3):607-614. PubMed ID: 33435706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
    Li H; Tian S; Chen T; Cui Z; Shi N; Zhong X; Qiu K; Zhang J; Zeng T; Chen L; Zheng J
    Diabetes Obes Metab; 2020 Oct; 22(10):1897-1906. PubMed ID: 32469464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia.
    Klonoff DC; Messler J; Valk T; Jagannathan R; Pasquel FJ; Umpierrez GE
    J Diabetes Sci Technol; 2021 Sep; 15(5):1181-1187. PubMed ID: 34159841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection.
    Vargas-Vázquez A; Bello-Chavolla OY; Ortiz-Brizuela E; Campos-Muñoz A; Mehta R; Villanueva-Reza M; Bahena-López JP; Antonio-Villa NE; González-Lara MF; Ponce de León A; Sifuentes-Osornio J; Aguilar-Salinas CA
    BMJ Open Diabetes Res Care; 2021 Feb; 9(1):. PubMed ID: 33593750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
    Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
    J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes.
    Mithal A; Jevalikar G; Sharma R; Singh A; Farooqui KJ; Mahendru S; Krishnamurthy A; Dewan A; Budhiraja S
    Diabetes Metab Syndr; 2021; 15(1):169-175. PubMed ID: 33360081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome.
    Vergès B; Avignon A; Bonnet F; Catargi B; Cattan S; Cosson E; Ducrocq G; Elbaz M; Fredenrich A; Gourdy P; Henry P; Lairez O; Leguerrier AM; Monpère C; Moulin P; Vergès-Patois B; Roussel R; Steg G; Valensi P; ;
    Arch Cardiovasc Dis; 2012 Apr; 105(4):239-53. PubMed ID: 22808525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. At-admission hyperglycemia is consistently associated with poor prognosis and early intervention can improve outcomes in patients with COVID-19.
    Singh AK; Singh R
    Diabetes Metab Syndr; 2020; 14(6):1641-1644. PubMed ID: 32896795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
    Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.
    Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1777-1781. PubMed ID: 32942253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
    Ma WX; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):146-150. PubMed ID: 32220179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.